Over 90 researchers convened at the 4th TPD & Induced Proximity Symposium to discuss advancements in targeted protein degradation (TPD) and induced proximity. Key topics included chemoproteomics' role in drug discovery and the integration of AI with mass spectrometry. The meeting underscored the growing community's commitment to translating proteomic insights into therapeutic innovations. The post Targeted Protein Degradation: How Chemoproteomics and Induced Proximity Are Shaping Drug Discovery